DAVID GUYER

Corporate Board Profile

Tech Score: 0/100

← Back to All Directors

EyePoint Pharmaceuticals, Inc.

Filing Date Source Excerpt
2020-10-16 David Guyer 26,666 *
2022-09-28 David Guyer Compensation Summary The following table and footnotes provide information regarding the compensation paid to our non-executive directors for the year ended December 31, 2021... No mention of software or technical background.

Data sourced from SEC filings. Last updated: 2026-03-05